TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
Carmel Pharma AB
Closing information (x1000 NOK)
| Closing information | 2023/09 | 2022/09 | 2021/09 |
| Turnover |
70,160
|
65,276
|
56,418 |
| Financial expenses |
2
|
1
|
8 |
| Earnings before taxes |
80,907
|
65,317
|
58,161 |
| EBITDA |
68,695
|
64,182
|
55,036 |
| Total assets |
443,238
|
472,259
|
424,551 |
| Current assets |
1,774
|
14,951
|
21,996 |
| Current liabilities |
82,305
|
119,291
|
394 |
| Equity capital |
360,933
|
352,968
|
367,920 |
| - share capital |
8,691
|
8,500
|
8,858 |
| Employees (average) |
0
|
0
|
0 |
Financial ratios
| Fiscal year | 2023/09 | 2022/09 | 2021/09 |
| Solvency |
81.4%
|
74.7%
|
86.7% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
115.3%
|
100.1%
|
103.1% |
| Return on assets (ROA) |
18.3%
|
13.8%
|
13.7% |
| Current ratio |
2.2%
|
12.5%
|
5582.7% |
| Return on equity (ROE) |
22.4%
|
18.5%
|
15.8% |
| Change turnover |
3,420
|
11,139
|
-9,051 |
| Change turnover % |
5%
|
21%
|
-14% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2023/09 | 2022/09 | 2021/09 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.